Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion

被引:290
作者
August, Gilbert P. [1 ]
Caprio, Sonia [2 ]
Fennoy, Ilene [3 ]
Freemark, Michael [4 ]
Kaufman, Francine R. [5 ]
Lustig, Robert H. [6 ]
Silverstein, Janet H. [7 ]
Speiser, Phyllis W. [8 ]
Styne, Dennis M. [9 ]
Montori, Victor M. [10 ]
机构
[1] George Washington Univ, Sch Med, Washington, DC 20037 USA
[2] Yale Univ, Sch Med, New Haven, CT 06510 USA
[3] Columbia Univ, New York, NY 10027 USA
[4] Duke Univ, Med Ctr, Durham, NC 27710 USA
[5] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Univ Florida, Gainesville, FL 32611 USA
[8] Schneider Childrens Hosp, New Hyde Pk, NY 11040 USA
[9] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA
[10] Mayo Clin, Rochester, MN 55905 USA
关键词
D O I
10.1210/jc.2007-2458
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Our objective was to formulate practice guidelines for the treatment and prevention of pediatric obesity. Conclusions: We recommend defining overweight as body mass index (BMI) in at least the 85th percentile but < the 95th percentile and obesity as BMI in at least the 95th percentile against routine endocrine studies unless the height velocity is attenuated or inappropriate for the family background or stage of puberty; referring patients to a geneticist if there is evidence of a genetic syndrome; evaluating for obesity-associated comorbidities in children with BMI in at least the 85th percentile; and prescribing and supporting intensive lifestyle (dietary, physical activity, and behavioral) modification as the prerequisite for any treatment. We suggest that pharmacotherapy (in combination with lifestyle modification) be considered in: 1) obese children only after failure of a formal program of intensive lifestyle modification; and 2) overweight children only if severe comorbidities persist despite intensive lifestyle modification, particularly in children with a strong family history of type 2 diabetes or premature cardiovascular disease. Pharmacotherapy should be provided only by clinicians who are experienced in the use of antiobesity agents and aware of the potential for adverse reactions. We suggest bariatric surgery for adolescents with BMI above 50 kg/m(2), or BMI above 40 kg/m(2) with severe comorbidities in whom lifestyle modifications and/or pharmacotherapy have failed. Candidates for surgery and their families must be psychologically stable and capable of adhering to lifestyle modifications. Access to experienced surgeons and sophisticated multidisciplinary teams who assess the benefits and risks of surgery is obligatory. We emphasize the prevention of obesity by recommending breast-feeding of infants for at least 6 months and advocating that schools provide for 60 min of moderate to vigorous daily exercise in all grades. We suggest that clinicians educate children and parents through anticipatory guidance about healthy dietary and activity habits, and we advocate for restricting the availability of unhealthy food choices in schools, policies to ban advertising unhealthy food choices to children, and community redesign to maximize opportunities for safe walking and bike riding to school, athletic activities, and neighborhood shopping. (J Clin Endocrinol Metab 93: 4576-4599, 2008)
引用
收藏
页码:4576 / 4599
页数:24
相关论文
共 269 条
[1]   Proteinuria and focal segmental glomerulosclerosis in severely obese adolescents [J].
Adelman, RD ;
Restaino, IG ;
Alon, US ;
Blowey, DL .
JOURNAL OF PEDIATRICS, 2001, 138 (04) :481-485
[2]   Nonalcoholic fatty liver disease [J].
Alfie, ME ;
Treem, WR .
PEDIATRIC ANNALS, 2006, 35 (04) :290-+
[3]  
Allen HF, 2005, J PEDIATR ENDOCR MET, V18, P761
[4]   Quantitative trait loci on chromosome 8q24 for pancreatic β-cell function and 7q11 for insulin sensitivity in obese nondiabetic white and black families -: Evidence from genome-wide linkage scans in the NHLBI Hypertension Genetic Epidemiology Network (HyperGEN) study [J].
An, P ;
Freedman, BI ;
Rich, SS ;
Mandel, SA ;
Arnett, DK ;
Myers, RH ;
Chen, YDI ;
Hunt, SC ;
Rao, DC .
DIABETES, 2006, 55 (02) :551-558
[5]   Physical activity and clustered cardiovascular risk in children: a cross-sectional study (The European Youth Heart Study) [J].
Andersen, Lars Bo ;
Harro, Maarike ;
Sardinha, Luis B. ;
Froberg, Karsten ;
Ekelund, Ulf ;
Brage, Soren ;
Anderssen, Sigmund Alfred .
LANCET, 2006, 368 (9532) :299-304
[6]  
Anderson JW, 2001, AM J CLIN NUTR, V74, P579
[7]  
Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P949
[8]   Best practice guidelines in pediatric/adolescent weight loss surgery [J].
Apovian, CM ;
Baker, C ;
Ludwig, DS ;
Hoppin, AG ;
Hsu, G ;
Lenders, C ;
Pratt, JSA ;
Forse, RA ;
O'Brien, A ;
Tarnoff, M .
OBESITY RESEARCH, 2005, 13 (02) :274-282
[9]   Childhood body-mass index and the risk of coronary heart disease in adulthood [J].
Baker, Jennifer L. ;
Olsen, Lina W. ;
Sorensen, Thorkild I. A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (23) :2329-2337
[10]   Longitudinal changes in insulin sensitivity, insulin secretion, and β-cell function during puberty [J].
Ball, GDC ;
Huang, TTK ;
Gower, BA ;
Cruz, ML ;
Shaibi, GQ ;
Weigensberg, MJ ;
Goran, MI .
JOURNAL OF PEDIATRICS, 2006, 148 (01) :16-22